Page 2 - Diabetes In India

PharmEasy report finds 1 in 2 Indians tested have high blood sugar

Half of India's HbA1c test results fall in the diabetic range, PharmEasy report finds, warning of a growing diabetes crisis driven by lifestyle, regional, and gender disparities

Nuvama retains 'Hold' on Cipla, raises target after Eli Lilly diabetes deal

Cipla- Eli Lilly deal: Tirzepatide is a prescription drug used for managing type 2 diabetes and aiding weight loss in adults who are obese or overweight.

India to get Novo Nordisk's Ozempic soon as demand for obesity drugs surges

Novo Nordisk's Ozempic launch adds to its GLP-1 portfolio, offering patients new options while competing with Eli Lilly's Mounjaro in India

Are you at risk of prediabetes? Know the symptoms, and risk factors

Prediabetes may have no clear symptoms, but early detection and small lifestyle changes can help reverse the risk

India's chronic disease surge hits women hardest, defying global trend

A new Lancet report highlights that India is among the few nations of the world where mortality due to non-communicable diseases increased over the past decade, bucking global improvements

Cannabis use may quadruple diabetes risk within five years, warns study

A massive study of over 4 million adults finds cannabis users face fourfold risk of type 2 diabetes within five years, raising new questions on its safety profile

It's not just cancer: Smoking may trigger all types of type-2 diabetes

From insulin resistance to insulin deficiency, smoking raises the risk of every type-2 diabetes form - and the more you smoke, the worse it gets, says new study

Can low blood sugar make you faint? Sweden's health minister collapsed on TV

A sudden blood sugar crash caused Sweden's new health minister to faint on live TV-here's why hypoglycaemia happens, who's at risk, and how to stay safe

Undiagnosed diabetes poses major global health risk, warns new study

A global study reveals that millions go undiagnosed with diabetes. Researchers call for better education, early screening, and affordable treatment access

Nearly 44% of diabetics undiagnosed in 2023, India sees 14% rise: Study

About 44 per cent of the world's diabetics were undiagnosed in 2023, while underdiagnosis and sub-optimal management of glycaemic index continue to pose major challenges in low- and middle-income countries, according to an analysis. Estimates published in The Lancet Diabetes and Endocrinology journal show that 43.6 per cent of India's diabetic population were diagnosed with the condition in 2023, an increase of about 14 per cent in diagnosis rates seen in 2000. Over 97 per cent of those diagnosed were under treatment in 2023, an international team of researchers forming the 'Global Burden of Disease' (GBD) study found. More than 55 per cent of people aged 15 and above around the world were diagnosed with diabetes, the analysis of data collected during 2000-2023 from across 204 countries and territories revealed. "By 2050, 1.3 billion people are expected to be living with diabetes, and if nearly half don't know they have a serious and potentially deadly health condition, it could ..

Neck size may reveal more about your health than you realise, say doctors

Doctors highlight that a thicker neck may reflect hidden fat distribution in the body, raising chances of insulin resistance, high blood pressure, and cardiovascular disease

Eating French fries often raises diabetes risk, Harvard study warns

A study tracking 200,000 US adults reveals eating French fries three times a week can increase type 2 diabetes risk by 20% while boiled or baked potatoes show no such link when eaten in moderation

One-fifth of Indians aged 45 and above had diabetes in 2019: Study

About a fifth of those aged 45 and above were living with diabetes in 2019, with two in every five possibly unaware of their condition, according to data from a study among India's ageing adults. Findings published in The Lancet Global Health also suggest that as the country's population rapidly ages, diabetes cases among the middle-aged and older adults will increase, even if increase in prevalence of the condition in age-specific groups can be arrested, authors said. Researchers, including those from the International Institute for Population Sciences, Mumbai, and US, also found that 46 per cent of those aware of their diabetes regained a control over blood sugar levels, while around 60 per cent were able to control their blood pressure the same year. Six per cent were taking a lipid-lowering medication to reduce the risk of cardiovascular disease, the team said. The 'Longitudinal Aging Study in India' (LASI), which surveyed about 60,000 adults aged 45 and above during 2017-2019

Kitchen to bloodstream: 'Forever chemicals' may raise your diabetes risk

Mount Sinai findings link PFAS exposure to type 2 diabetes as the global numbers continue to surge at alarming levels

Why jamun seed powder is called a superfood for managing diabetes

Jamun seed powder contains jamboline and jambosine that help regulate blood sugar, support pancreatic function, and may aid in diabetes prevention if used correctly

Understanding gestational diabetes: Why early detection, awareness matter

Despite common misconceptions, gestational diabetes can affect healthy women of any age or body type. Often symptomless, it frequently goes undiagnosed-putting both mother and child at risk

Does your job involve meeting people? It may raise diabetes risk: Study

A 14-year study of nearly 3 million people found that emotional strain in public-facing roles may increase type 2 diabetes risk by up to 47 per cent

That 'healthy' juice habit? It might be messing with your metabolism

Think juice is better than soda? A large new study shows even 100% fruit juice raises diabetes risk, urging people to eat whole fruits instead

Lilly's obesity drug Mounjaro's sales rise 60% in India amid rising demand

The US drugmaker sold ₹12.6 crore ($1.5 million) worth of the injections last month, according to market analysis firm Pharmarack Technologies

Novo Nordisk to launch weight-loss drug Wegovy in India ahead of schedule

Amid rising demand and Eli Lilly's Mounjaro launch, Novo Nordisk is advancing plans to introduce its obesity drug Wegovy in the Indian market